Structural and Biochemical Studies of TIGAR (TP53-induced Glycolysis and Apoptosis Regulator)

被引:97
|
作者
Li, Hua [1 ]
Jogl, Gerwald [1 ]
机构
[1] Brown Univ, Dept Biochem Mol Biol & Cell Biol, Providence, RI 02912 USA
基金
美国国家卫生研究院;
关键词
PHOSPHOGLYCERATE MUTASE HOMOLOG; BROAD-SPECIFICITY PHOSPHATASE; BACILLUS-STEAROTHERMOPHILUS; FRUCTOSE 2,6-BISPHOSPHATE; CRYSTAL-STRUCTURE; BIFUNCTIONAL ENZYME; METABOLISM; PROTEIN; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE; FRUCTOSE-2,6-BISPHOSPHATASE;
D O I
10.1074/jbc.M807821200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of the p53 tumor suppressor by cellular stress leads to variable responses ranging from growth inhibition to apoptosis. TIGAR is a novel p53-inducible gene that inhibits glycolysis by reducing cellular levels of fructose-2,6-bisphosphate, an activator of glycolysis and inhibitor of gluconeogenesis. Here we describe structural and biochemical studies of TIGAR from Danio rerio. The overall structure forms a histidine phosphatase fold with a phosphate molecule coordinated to the catalytic histidine residue and a second phosphate molecule in a position not observed in other phosphatases. The recombinant human and zebra fish enzymes hydrolyze fructose-2,6-bisphosphate as well as fructose-1,6-bisphosphate but not fructose 6-phosphate in vitro. The TIGAR active site is open and positively charged, consistent with its enzymatic function as bisphosphatase. The closest related structures are the bacterial broad specificity phosphatase PhoE and the fructose-2,6-bisphosphatase domain of the bifunctional 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. The structural comparison shows that TIGAR combines an accessible active site as observed in PhoE with a charged substrate-binding pocket as seen in the fructose-2,6-bisphosphatase domain of the bifunctional enzyme.
引用
收藏
页码:1748 / 1754
页数:7
相关论文
共 50 条
  • [1] TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Is Upregulated in Lymphocytes Stimulated with Concanavalin A
    Simon-Molas, Helga
    Vallve-Martinez, Xavier
    Caldera-Quevedo, Irene
    Fontova, Pere
    Arnedo-Pac, Claudia
    Vidal-Alabro, Anna
    Castano, Esther
    Navarro-Sabate, Aurea
    Lloberas, Nuria
    Bartrons, Ramon
    Manzano, Anna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (14)
  • [2] TP53-induced glycolysis and apoptosis regulator (TIGAR) induces NADPH production and growth in nasopharyngeal carcinoma cells
    Lam, Emily K. Y.
    Lui, Vivian W. Y.
    Wong, Elaine Y. L.
    Lau, Cecilia P. Y.
    Nong, Cesar S. C.
    Hui, Edwin P.
    Chan, Andrew S. K.
    Tsao, Sai Wah
    Mills, Gordon B.
    Chan, Anthony T. C.
    CANCER RESEARCH, 2011, 71
  • [3] Knockdown of the TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Sensitizes Glioma Cells to Hypoxia, Irradiation and Temozolomide
    Maurer, Gabriele D.
    Heller, Sonja
    Wanka, Christina
    Rieger, Johannes
    Steinbach, Joachim P.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (05):
  • [4] Identification of TP53-induced glycolysis and apoptosis regulator (TIGAR) as the phosphoglycolate-independent 2,3-bisphosphoglycerate phosphatase
    Gerin, Isabelle
    Noel, Gaetane
    Bolsee, Jennifer
    Haumont, Olivier
    Van Schaftingen, Emile
    Bommer, Guido T.
    BIOCHEMICAL JOURNAL, 2014, 458 : 439 - 448
  • [5] The Expression of TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Can Be Controlled by the Antioxidant Orchestrator NRF2 in Human Carcinoma Cells
    Simon-Molas, Helga
    Sanchez-de-Diego, Cristina
    Navarro-Sabate, Aurea
    Castano, Esther
    Ventura, Francesc
    Bartrons, Ramon
    Manzano, Anna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [6] TP53-induced glycolysis and apoptosis regulator promotes proliferation and invasiveness of nasopharyngeal carcinoma cells
    Wong, Elaine Yue Ling
    Wong, Sze-Chuen Cesar
    Chan, Charles Ming Lok
    Lam, Emily Kai Yee
    Ho, Louisa Yeung
    Lau, Cecilia Pik Yuk
    Au, Thomas Chi Chuen
    Chan, Amanda Kit Ching
    Tsang, Chi Man
    Tsao, Sai Wah
    Lui, Vivian Wai Yan
    Chan, Anthony Tak Cheung
    ONCOLOGY LETTERS, 2015, 9 (02) : 569 - 574
  • [7] Identification of the TP53-induced glycolysis and apoptosis regulator in various stages of colorectal cancer patients
    Al-Khayal, Khayal
    Abdulla, Maha
    Al-Obeed, Omar
    Al Kattan, Wael
    Zubaidi, Ahmad
    Vaali-Mohammed, Mansor-Ali
    Alsheikh, Abdulmalik
    Ahmad, Rehan
    ONCOLOGY REPORTS, 2016, 35 (03) : 1281 - 1286
  • [8] Potent effects of dioscin against hepatocellular carcinoma through regulating TP53-induced glycolysis and apoptosis regulator (TIGAR)-mediated apoptosis, autophagy, and DNA damage
    Mao, Zhang
    Han, Xu
    Chen, Dahong
    Xu, Youwei
    Xu, Lina
    Yin, Lianhong
    Sun, Huijun
    Qi, Yan
    Fang, Lingling
    Liu, Kexin
    Peng, Jinyong
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (07) : 919 - 937
  • [9] TP53 induced glycolysis and apoptosis regulator (TIGAR) knockdown results in radiosensitization of glioma cells
    Pena-Rico, Miguel A.
    Nieves Calvo-Vidal, Maria
    Villalonga-Planells, Ruth
    Martinez-Soler, Fina
    Gimenez-Bonafe, Pepita
    Navarro-Sabate, Aurea
    Tortosa, Avelina
    Bartrons, Ramon
    Manzano, Anna
    RADIOTHERAPY AND ONCOLOGY, 2011, 101 (01) : 132 - 139
  • [10] TP53-induced glycolysis and apoptosis regulator is indispensable for mitochondria quality control and degradation following damage
    Feng, Jing
    Luo, Li
    Liu, Yong
    Fu, Shaozhi
    Chen, Jie
    Duan, Xiaoxia
    Xiang, Li
    Zhang, Yanling
    Wu, Jinbo
    Fan, Juan
    Wen, Qinglian
    Zhang, Ye
    Yang, Jingpin
    Peng, Jinxia
    Zhao, Ming
    Yang, Linglin
    ONCOLOGY LETTERS, 2018, 15 (01) : 155 - 160